Home » Topics » BioWorld Science

BioWorld Science
RSS

New antitumor agents developed by Sanofi-Synthelabo scientists

June 16, 2004

Nordic Bioscience researchers claim new GADPH and/or IAMP inhibitors

June 16, 2004

Novel GABA-A ligands and their use covered by Merck patent

June 16, 2004

Cyclodextrin complexes of opioid peptide and their use in pain and inflammation

June 16, 2004

New HIV integrase inhibitors discovered by Pfizer researchers

June 16, 2004

Novel prostaglandin D2 antagonists under study at Merck Frosst

June 16, 2004

Autologous Xcellerated T-cells show antitumor efficacy in phase I/II clinical trials

June 16, 2004

Two series of mitotic kinesin KSP inhibitors claimed by Merck

June 16, 2004

Promising effects of the protease inhibitor PL-100 against resistant HIV strains

June 16, 2004

Therapeutic benefits of PT-141 plus Viagra in erectile dysfunction

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...